Stock Events

Stock Events

AMGEN 

$329.59
3757
+$5.74+1.77% Tuesday 20:00

Statistics

Day High
329.66
Day Low
320.53
52W High
387.96
52W Low
262.28
Volume
3,316,268
Avg. Volume
-
Mkt Cap
177.67B
P/E Ratio
22.94
Dividend Yield
3.06%
Dividend
10.08

Upcoming

15
MAY
Dividend Ex
 
5
JUN
Dividend Payment
 
24
AUG
Dividend Ex
Estimated
 
11
SEP
Dividend Payment
Estimated
 
23
NOV
Dividend Ex
Estimated
 

Dividends

3.06%Dividend Yield
Jun 26
$2.52
Mar 26
$2.52
Dec 25
$2.38
Sep 25
$2.38
Jun 25
$2.38
10Y Growth
9.68%
5Y Growth
7.44%
3Y Growth
5.76%
1Y Growth
5.88%

Earnings

30JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
4.27
4.85
5.44
6.02
Expected EPS
5.618416
Actual EPS
N/A

Financials

20.98%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
73.5BRevenue
15.42BNet Income

Analyst Ratings

362Average Price Target
The highest estimate is 432.00.
From 14 ratings within the last 6 months. This is not an investment recommendation.
Buy
29%
Hold
71%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AMGN. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap163.4B
Gilead Sciences competes in the biopharmaceutical sector focusing on antiviral drugs, similar therapeutic areas as Amgen.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie operates in the same biopharmaceutical space, with a strong presence in immunology and oncology, directly competing with Amgen's product lines.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol Myers Squibb is a major player in the biopharmaceutical industry, with a focus on cancer and immune system disorders, overlapping with Amgen's market.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a global pharmaceutical company with a broad range of products that compete across several of Amgen's key therapeutic areas.
Merck
MRK
Mkt Cap277.02B
Merck & Co. focuses on pharmaceuticals including oncology, vaccines, and animal health, competing with Amgen in the oncology and biologic drugs market.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in the immunology and oncology sectors, similar to Amgen.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.54B
Regeneron Pharmaceuticals specializes in biopharmaceuticals, particularly in monoclonal antibodies, a direct competitor to Amgen's biologic treatments.
Novartis
NVS
Mkt Cap279.67B
Novartis is a global healthcare company that competes with Amgen in several areas, including biopharmaceuticals and generic drugs.
Rogers
ROG
Mkt Cap2.4B
Roche Holding AG, with its strong focus on oncology and immunotherapy, competes directly with Amgen in the biopharmaceutical and diagnostics sectors.
Sanofi
SNY
Mkt Cap110.4B
Sanofi operates globally in the pharmaceutical sector, with a focus on diabetes, oncology, and rare diseases, areas where Amgen also has significant interests.

About

There is no Profile data available for AMG.SG.
Show more...
CEO
Mr. Robert A. Bradway
Employees
28000
Country
United States
ISIN
US0311621009

Listings

F
DE
AMG0.F
NEO
CA
AMGN.NEO
STU
DE
AMG.STU
MU
DE
AMG.MU

0 Comments

Share your thoughts

FAQ

What is AMGEN stock price today?▼
The current price of AMGN is $329.59 USD — it has increased by +1.77% in the past 24 hours. Watch AMGEN stock price performance more closely on the chart.
What is AMGEN stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange AMGEN stocks are traded under the ticker AMGN.
Is AMGEN stock price growing?▼
AMGN stock has fallen by -2.49% compared to the previous week, the month change is a -3.79% fall, over the last year AMGEN has showed a +21.87% increase.
What is AMGEN market cap?▼
Today AMGEN has the market capitalization of 177.67B
When is the next AMGEN earnings date?▼
AMGEN is going to release the next earnings report on July 30, 2026.
What were AMGEN earnings last quarter?▼
AMGN earnings for the last quarter are 5.15 USD per share, whereas the estimation was 4.77 USD resulting in a +8.04% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is AMGEN revenue for the last year?▼
AMGEN revenue for the last year amounts to 73.5B USD.
What is AMGEN net income for the last year?▼
AMGN net income for the last year is 15.42B USD.
Does AMGEN pay dividends?▼
Yes, AMGN dividends are paid quarterly. The last dividend per share was 2.52 USD. As of today, Dividend Yield (FWD)% is 3.06%.
How many employees does AMGEN have?▼
As of May 06, 2026, the company has 28,000 employees.
In which sector is AMGEN located?▼
AMGEN operates in the Health & Wellness sector.
When did AMGEN complete a stock split?▼
AMGEN has not had any recent stock splits.
Where is AMGEN headquartered?▼
AMGEN is headquartered in Thousand Oaks, United States.